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Background: Based on clinical trial protocols, high dose aspirin (162-325 mg/day) is recommended for 1-6 mon after PCI. We hypothesized that 
low dose aspirin is as efficacious as higher doses in preventing death/MI and stent thrombosis (ST) after PCI.
Methods: We studied 2820 consecutive pts who underwent successful PCI with BMS or DES at our center for stable or unstable CAD (excluding 
cardiogenic shock) between 2001- 2007 and were released alive without post-procedural MI, TVR, or stroke. Depending on the discharge dose 
of aspirin, pts were divided into low dose (81 mg/day, N=313) or high dose (162-325 mg/day, N=2507) groups. All pts were advised to take a 
thienopyridine for 1-12 months. We assessed the occurrence of ST (definite or probable by ARC criteria) and the composite end-point of death/MI at 
1 year after PCI. Using propensity-adjusted Cox regression, we evaluated the independent impact of aspirin dose on outcomes. Similar analyses were 
performed in 3 pre-defined subsets: pts presenting with NSTEMI or STEMI (N=1132); diabetics (N=751); and those who received DES (N=1488).
Results: In the low dose versus high dose groups, ST occurred in 2.2 vs 1.8% (p=0.55), and death/MI in 6.7 vs 6.1% (p=0.69, figure), respectively. 
In multivariate analysis, aspirin dose did not show an independent association with study outcomes. Similar results were seen in the 3 sub-groups.
Conclusions: In this observational study, low dose aspirin appears to be as effective as higher doses in the prevention of ST and death/MI after 
PCI. 
